Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7 (original) (raw)

• Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell 81, 323–330 (1995).
  Article CAS Google Scholar
• Yandell, D. W. et al. Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling. New Engl. J. Med. 321, 1689–1695 (1989).
  Article CAS Google Scholar
• Horowotiz, J. M. et al. Point mutational inactivation of the retinoblastoma antioncogene. Science 243, 937–940 (1989).
  Article ADS Google Scholar
• Kaye, F. J., Kratzke, R. A., Ferster, J. L. & Horowitz, J. M. Asingle amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc. Natl Acad. Sci. USA 87, 6922–6926 (1990).
  Article ADS CAS Google Scholar
• Onadim, Z., Hogg, A., Baird, P. N. & Cowell, J. K. Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype. Proc. Natl Acad. Sci. USA 89, 6177–6181 (1992).
  Article ADS CAS Google Scholar
• Dyson, N., Howley, P. M., Munger, K. & Harlow, E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243, 934–937 (1989).
  Article ADS CAS Google Scholar
• zur Hausen, H. Papillomavirus infections: a major cause of human cancers. Biochim. Biophys. Acta 1288, f55–f58 (1996).
  PubMed Google Scholar
• Bookstein, R., Shew, J. Y., Chen, P. L., Scully, P. & Lee, W. H. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247, 712–715 (1990).
  Article ADS CAS Google Scholar
• Huang, H. J. et al. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242, 1563–1566 (1988).
  Article ADS CAS Google Scholar
• Qin, X. Q., Chittenden, T., Livingston, D. M. & Kaelin, W. G. J Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6, 953–964 (1992).
  Article CAS Google Scholar
• Goodrich, D. W., Wang, N. P., Qian, Y. W., Lee, E. Y. & Lee, W. H. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67, 293–302 (1991).
  Article CAS Google Scholar
• Hinds, P. W. et al. Regulation of the retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70, 993–1006 (1992).
  Article CAS Google Scholar
• Buchkovich, K., Duffy, L. A. & Harlow, E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58, 1097–1105 (1989).
  Article CAS Google Scholar
• Helin, K. et al. AcDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70, 33–50 (1992).
  Article Google Scholar
• Kaelin, W. G. J et al. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70, 351–364 (1992).
  Article CAS Google Scholar
• Hiebert, S. W., Chellappan, S. P., Horowitz, J. M. & Nevins, J. R. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes. Dev. 6, 177–185 (1992).
  Article CAS Google Scholar
• Flemington, E. K., Speck, S. H. & Kaelin, W. G. J E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl Acad. Sci. USA 90, 6914–6918 (1993).
  Article ADS CAS Google Scholar
• Helin, K., Harlow, E. & Fattaey, A. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13, 6501–6508 (1993).
  Article CAS Google Scholar
• Weintraub, S. J. et al. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375, 812–815 (1995).
  Article ADS CAS Google Scholar
• Sellers, W. R., Rodgers, J. W. & Kaelin, W. G. J Apotent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl Acad. Sci. USA 92, 11544–11548 (1995).
  Article ADS CAS Google Scholar
• Herber, R., Liem, A., Pitot, H. & Lambert, P. F. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. J. Virol. 70, 1873–1881 (1996).
  CAS PubMed PubMed Central Google Scholar
• Chellappan, S. et al. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl Acad. Sci. USA 89, 4549–4553 (1992).
  Article ADS CAS Google Scholar
• Munger, K. et al. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8, 4099–4105 (1989).
  Article CAS Google Scholar
• DeCaprio, J. A. et al. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54, 275–283 (1988).
  Article CAS Google Scholar
• Whyte, P. et al. Association between an oncogene and an anti-oncogene: the advenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334, 124–129 (1988).
  Article ADS CAS Google Scholar
• Gulliver, G. A., Herber, R. L., Liem, A. & Lambert, P. F. Both conserved region 1 (CR1) and CR2 of the human papillomavirus type 16 E7 oncogene are required for induction of epidermal hyperplasia and tumor formation in transgenic mice. J. Virol. 71, 5905–5914 (1977).
  Google Scholar
• Shan, B., Durfee, T. & Lee, W. H. Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc. Natl Acad. Sci. USA 93, 679–684 (1996).
  Article ADS CAS Google Scholar
• Hu, Q. J., Dyson, N. & Harlow, E. The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J. 9, 1147–1155 (1990).
  Article CAS Google Scholar
• Kaelin, W. G. J, Ewen, M. E. & Livingston, D. M. Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product. Mol. Cell. Biol. 10, 3761–3769 (1990).
  Article CAS Google Scholar
• Huang, S., Wang, N. P., Tseng, B. Y., Lee, W. H. & Lee, E. H. Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. EMBO J. 9, 1815–1822 (1990).
  Article CAS Google Scholar
• Jones, R. E. et al. Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein. J. Biol. Chem. 265, 12782–12785 (1990).
  CAS PubMed Google Scholar
• Chow, K. N. & Dean, D. C. Domains A and B in the Rb pocket interact to form a transcriptional repressor motif. Mol. Cell. Biol. 16, 4862–4868 (1996).
  Article CAS Google Scholar
• Kim, H. Y. & Cho, Y. Structural similarity between the pocket region of retinoblastoma tumour suppressor and the cyclin-box. Nature Struct. Biol. 4, 390–395 (1997).
  Article CAS Google Scholar
• Gibson, T. J., Thompson, J. D., Blocker, A. & Kouzarides, T. Evidence for a protein domain superfamily shared by the cyclins, TFIIB and RB/p107. Nucleic Acids Res. 22, 946–952 (1994).
  Article CAS Google Scholar
• Jeffrey, P. D. et al. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376, 313–320 (1995).
  Article ADS CAS Google Scholar
• Nikolov, D. B. et al. Crystal structure of a TFIIB-TBP-TATA-element ternary complex. Nature 377, 119–128 (1995).
  Article ADS CAS Google Scholar
• Grafi, G. et al. Amaize cDNA encoding a member of the retinoblastoma protein family: involvement in endoreduplication. Proc. Natl Acad. Sci. USA 93, 8962–8967 (1996).
  Article ADS CAS Google Scholar
• Dyson, N., Buchkovich, K., Whyte, P. & Harlow, E. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 58, 249–255 (1989).
  Article CAS Google Scholar
• Kratzke, R. A. et al. Partial inactivation of the RB product in a family with incomplete penetrance of familial retinoblastoma and benign retinal tumors. Oncogene 9, 1321–1326 (1994).
  CAS PubMed Google Scholar
• Kitagawa, M. et al. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 15, 7060–7069 (1996).
  Article CAS Google Scholar
• Knudsen, E. S. & Wang, J. Y. J. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J. Biol. Chem. 271, 8313–8320 (1996).
  Article CAS Google Scholar
• O'Connor, R. J. & Hearing, P. Mutually exclusive interaction of the adenovirus E4-6/7 protein and the retinoblastoma gene product with internal domains of E2F-1 and DP-1. J. Virol. 68, 6848–6862 (1994).
  CAS PubMed PubMed Central Google Scholar
• Wu, E. W., Clemens, K. E., Heck, D. V. & Munger, K. The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein. J. Virol. 67, 2402–2407 (1993).
  CAS PubMed PubMed Central Google Scholar
• Ikeda, M. A. & Nevins, J. R. Identification of distinct roles for separate E1A domains in disruption of E2F complexes. Mol. Cell. Biol. 13, 7029–7035 (1993).
  Article CAS Google Scholar
• Fattaey, A. R., Harlow, E. & Helin, K. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes. Mol. Cell. Biol. 13, 7267–7277 (1993).
  Article CAS Google Scholar
• Collaborative Computational Project B. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760–763 (1994).
• Jones, T. A., Zhou, J.-Y., Cowan, S. W. & Kjeldgaard, M. Improved methods for building protein models in electron density maps and the location of erros in these models. Acta Crystallogr. A 47, 110–119 (1991).
  Article Google Scholar
• Brunger, A. T. X-PLOR, a System for Crystallography and NMR(Yale Univ. Press, New Haven, CT, 1991).
  Google Scholar